Literature DB >> 2205261

Interleukin-2 in the treatment of HIV disease.

D H Schwartz1, T C Merigan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2205261     DOI： 10.1007/bf02173452

Source DB:  PubMed          Journal:  Biotherapy        ISSN： 0921-299X


× No keyword cloud information.
  4 in total

1.  Effects of cytokines on antiviral pharmacokinetics: an alternative approach to assessment of drug interactions using bioequivalence guidelines.

Authors:  S C Piscitelli; M A Amatea; S Vogel; C Bechtel; J A Metcalf; J A Kovacs
Journal:  Antimicrob Agents Chemother       Date:  1996-01       Impact factor: 5.191

2.  Changes in natural immunity during the course of HIV-1 infection.

Authors:  B G Brenner; C Gryllis; M Gornitsky; M A Wainberg
Journal:  Clin Exp Immunol       Date:  1993-08       Impact factor: 4.330

3.  Increased LAK activity against HIV-infected cell lines in HIV-1+ individuals.

Authors:  C Gryllis; M A Wainberg; Z Bentwich; M Gornitsky; B G Brenner
Journal:  Clin Exp Immunol       Date:  1992-09       Impact factor: 4.330

Review 4.  Interleukin-2 and human immunodeficiency virus infection: pathogenic mechanisms and potential for immunologic enhancement.

Authors:  A Kinter; A S Fauci
Journal:  Immunol Res       Date:  1996       Impact factor: 2.829
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.